PUBLISHED DATE : Apr 2022 | Pages : 265
Fill out your details & get your free sample
Global Ophthalmic Implants Market Share, Size Trends, Analysis By
Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast, 2022-2027
265 Pages
76 Tables
121 Charts
5 Regions
18 Countries
28 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (2027) | USD 7 Billion |
| CAGR (2022-2027) | 6.5% |
| BASE YEAR | 2021 |
| FORECAST YEAR | 2022-2027 |
| LARGEST MARKET | North America |
| FASTEST MARKET | APAC |
| GEOGRAPHICAL ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
The ophthalmic implants market size was valued at USD 4 billion in 2021 and is expected to reach USD 7 billion by 2027, growing at a CAGR of 6.5%.
According to Arizton's market research report, the ophthalmic implants market size is expected to grow at a moderate rate between 2021 and 2027 due to the high prevalence of eye diseases in emerging and developing countries. Undiagnosed and untreated refractive errors, cataracts, age-related macular degeneration, glaucoma, diabetic retinopathy, corneal opacity, and trachoma are the main causes of poor eyesight. The most common and leading causes of blindness are cataracts and uncorrected refractive error. A cataract is higher in low- and middle-income countries than in high-income countries, while diabetic retinopathy, glaucoma, and age-related macular degeneration are more common in developed countries.
The global ophthalmic implants market is expected to grow at a remarkable 6.5% CAGR during the forecast period.
According to the ophthalmic implants market analysis report, the rise in demand for ophthalmic implants is increasing due to its wide usage to treat ophthalmologic illnesses such as glaucoma and diabetic retinopathy.
The global ophthalmic implants market is driven by an increase in the frequency of ophthalmic diseases and a steady rise in the geriatric population, who are more sensitive to eye ailments. The increasing number of regulatory approvals for ocular devices will help large companies to generate significant revenue in the ocular implant market.
To maintain their market share, the key players pursue various strategies such as agreements and collaborations with other industry players. For example, the STAAR Surgical Corporation announced a cooperation agreement with the World Eye Hospital Group. This strategic collaboration has enabled the company to become the largest provider of treatment solutions for refractive surgery in Southeastern Europe and is expected to open lucrative opportunities during the forecast period.
Technological advancement and increasing adoption of vision correction coupled with the rapid adoption of intraocular lenses in cataract surgery are the factors driving the ophthalmic implants market growth. For example, a new collagen glaucoma implant was developed that inhibits scarring and is biodegradable.
Eye research institutes play a crucial role in the technological advancement of intraocular lenses. The report will shed information on a variety of ophthalmic implants market categories. In addition, the study is expected to include critical information on the ocular implants market growth and current trends over the forecast year.
The increasing investment in research and development of new products such as ocular implants for drug delivery will have a direct impact on the ophthalmic implants market growth in the coming years. Advances in ophthalmic diagnostic technology have resulted in wider product adoption. The easy accessibility of online tools has educated the public about various treatment options and will help the market grow. The increasing acceptance of advanced ocular devices such as artificial eyes and glaucoma devices has opened the enormous potential for companies operating in the industry.
Growing Advancements in Ophthalmic Diagnostic Technology
The refractive lens is implanted into the patient to improve their vision rather than just repairing the clouded vision produced by their cataract. Toric IOLs, For instance, allow us to correct astigmatism and make patients spectacle-free for farsighted vision. The use of portable medical devices for home-based diagnosis and treatment of medical conditions is increasing as it allows diagnosis and monitoring of eye diseases at home. Artificial intelligence and machine learning equipped medical devices can not only quickly interpret the retina of the patient with greater accuracy but also recommend a suitable treatment for the patient.
Most of these individuals are in the geriatric age group, meaning they are over 50 years old. Given these large numbers, ophthalmic diagnostics investments have increased in the last year. The healthcare business has been severely impacted by technological innovations, and ophthalmology is no exception. Various sophisticated imaging and surgical treatments have made significant gains in this field in recent years, resulting in tremendous growth. Eyecare has been transformed since the introduction of optical coherence tomography or OCT. Hence, the growing advances in ophthalmic diagnostic technology are driving the industry during the forecast period.
Increasing Prevalence of Ophthalmic diseases
The CDC (Center for Disease Control and Prevention) states that the prominent causes of low vision and blindness in the US are age-related eye injuries such as age-related macular degeneration, cataracts, diabetic retinopathy, and glaucoma. Other common eye diseases are amblyopia and strabismus. About 4.2 million Americans ages 40 and older are either legally blind or partially sighted. The National Eye Institute states that adequate refractive surgery could improve the eyesight of 150 million Americans. 1.8 million Americans in the age of 40 are affected by AMD, and another 7.3 million with large drusen are at significant risk of developing AMD. The number of AMD patients is estimated to be 2.95 million in 2020.
According to World Health Organization WHO, 2.2 billion people worldwide have a near or far visual impairment. In at least 1 billion or nearly half of those cases, visual impairment could have been prevented or has yet to be addressed. Those 1 billion people include people with moderate or severe distant vision disorder or blindness due to unaddressed refractive error 88.4 million, cataracts 94 million, glaucoma 7.7 million, corneal opacities 4.2 million, diabetic retinopathy 3.9 million, and trachoma 2 million as well Close range The visual impairment caused by unaddressed presbyopia is 826 million. The advances in diagnostic technologies and research and development of new therapeutics to treat these disorders are expected to fuel market growth.
The Ocular Implants Market is segmented by product, application, end-user, and region.
The Intraocular Lenses are expected to witness the highest incremental growth and Glaucoma Implants are likely to witness the highest absolute growth during the forecast period. The rising cases of presbyopia, myopia, blindness, cataract surgery, and farsightedness are expected to drive demand for the global eye implant market. Other major reasons for the market's growth include increasing awareness of comprehensive eye care services, the surge in the geriatric population, and the inclusion of eye care services in the insurance system. The total number of patients undergoing cataract surgery has more than tripled in a decade, a key factor that has impacted players in the intraocular lens industry.
Cataract Surgery accounted for the major industry share, followed by Glaucoma Surgery which is likely to observe the highest absolute growth during the forecast period. When treating glaucoma, optical surgeons use either conventional glaucoma surgery or minimally invasive glaucoma surgery. Approximately 2.7 million Americans over 40 have open-angle glaucoma, 3.3 million have blindness or vision loss, and more than 3 million Americans have glaucoma. The increasing prevalence of glaucoma worldwide and the growing older population worldwide are key factors for the growth of the cataract surgery market. Increasing awareness of the treatment of this disease, advances in health infrastructure, and innovative developments in product technology are driving global ophthalmic implants market growth.
According to Alcon Inc., cataracts are the leading cause of vision loss worldwide. In the US it is anticipated that 5.4 million cataract surgeries would be done by 2025. The increasing prevalence of cataracts and technological advances in ophthalmic devices are driving the market. In addition, the global growth of the elderly population is driving industry growth. The lack of health insurance and people's low awareness of the benefits of cataract surgery could act as a barrier for the ophthalmic implants market.
Hospitals are expected to witness the highest incremental growth during the forecast period. The Hospital segment is the dominant segment in the ophthalmic implant market. Glaucoma drainage implant surgery is performed in an outpatient surgery center or hospital. This procedure usually takes about an hour or less. Hospitals are known for their long stays and the best care. Postoperative and preoperative care in puffy implants is important. These are done more in the hospital because they are well equipped for the surgery. Thus, the rise in the patient population approaching hospitals for treatment is expected to drive the market.
The increasing ageing population and raising awareness in the North American region are expected to drive the ophthalmic implants market size in the region. According to Population Reference Bureau, the number of Americans aged 65 and over is projected to nearly double from 52 million in 2018 to 95 million in 2060, with 16% to 23 of the population aged 65 and over. Percentage increase expected to increase in people. As the population ages, cataract and glaucoma surgery is on the rise. The National Eye Institute (NEI) is leading research to better prevent, detect, and treat this potentially catastrophic disease. In the early stages, glaucoma is usually asymptomatic. In the second half of the illness, when vision is lost, it cannot be restored. Thus, awareness of eye disease is driving and accelerating the demand for implants in the region. Product approval and launch in North America will also help market penetration. For instance, in September 2020, Roche's Genentech unit launched an eye implant designed to facilitate the use of Lucentis macular degeneration. North America is predicted to witness the highest incremental growth and APAC is likely to observe the highest absolute growth during the forecast period.
Advances in ophthalmic diagnostic technology have resulted in wider product adoption. The easy accessibility of online tools has educated the public about various treatment options and will help the market grow. The increasing acceptance of advanced ocular devices such as artificial eyes and glaucoma devices has opened up the potential for companies active in the market. The increasing number of regulatory approvals for corneal implants devices will help large companies generate significant revenue in the eye implant market in the years to come. The emergence of various advanced intraocular lenses and increased competition between manufacturers to develop better lenses, as well as an increase in investment in eye research institutes by government and non-governmental organizations are expected to fuel market growth. Due to the increasing number of clinical studies on these lenses and increasing government spending on research and development, lucrative growth in the market can be expected.
The Prominent players in the market are Alcon, Bausch & Lomb, Carl Zeiss, Johnson & Johnson and the other prominent key players are STAAR Surgical, MORCHER GmbH, Novartis AG, Pfizer Inc., OSD Medical GmbH, Ophtec BV, PhysIOL, Hoya Surgical Optics, Rayner Intraocular Lenses Limited, SAV-IOL SA., Glaukos, Second Sight, Allergan and many among the others.
Frequently Asked Questions
What is the market size and growth rate of the ophthalmic implants market?
The ophthalmic implants market to reach USD 7 billion by 2027 and growing at a CAGR of 6.5% during the forecast period.
Which region holds the largest share in the ophthalmic implants market?
North America holds the largest share in the market.
What are the growth enablers in the ophthalmic implants market?
Growing advancements in ophthalmic diagnostic technology, increasing adoption of advanced ocular devices, and rise in awareness about diagnosis & treatment of eye disorders are some of the growth enablers in the market.
What are the latest trends in the ophthalmic implants market?
Artificial intelligence for the detection of diabetic retinopathy, robotic surgical assistants for eye surgeries, and synthetic cornea implants are the latest trends in the ophthalmic implants market.
Who are the top players in the ophthalmic implants market?
Top players include ALCON, Johnson & Johnson, and Bausch & Lomb.
The global ophthalmic implant market was valued at USD 4.6 billion in 2021 and is expected to reach USD 6.8 billion by 2027, growing at a CAGR of 6.49% during 2022-2027.
The following factors are likely to contribute to the growth of the market during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the ophthalmic implant market and its market dynamics for the period 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
Market Segmentation by Product
Market Segmentation by Application
Market Segmentation by End-User
Market Segmentation by Region
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY END-USER
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
7.2 IMPACT OF COVID-19
8 MARKET OPPORTUNITIES & TRENDS
8.1 RISE OF ARTIFICIAL INTELLIGENCE FOR DETECTING DIABETIC RETINOPATHY
8.2 USE OF SYNTHETIC CORNEA IMPLANTS
8.3 INCREASE IN USE OF ROBOTIC SURGICAL ASSISTANTS FOR EYE SURGERIES
9 MARKET GROWTH ENABLERS
9.1 GROWING ADVANCEMENTS IN OPHTHALMIC DIAGNOSTIC TECHNOLOGY
9.2 INCREASING ADOPTION OF ADVANCED OCULAR DEVICES
9.3 INCREASE IN THE NUMBER OF CASES OF EYE-RELATED DISORDERS
9.4 RISE IN AWARENESS OF DIAGNOSIS & TREATMENT OF EYE DISORDERS
9.5 RISE IN PREFERENCE FOR MINIMALLY INVASIVE OPHTHALMIC SURGERY
10 MARKET RESTRAINTS
10.1 STRINGENT REGULATORY APPROVALS AND PRODUCT RECALLS
10.2 INCREASE IN RISK OF SURGERY FAILURE
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 MARKET SHARE BY PRODUCT
11.2.2 MARKET SHARE BY APPLICATION
11.2.3 MARKET SHARE BY END-USER
11.2.4 MARKET SHARE BY GEOGRAPHY
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 PRODUCT
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 INTRAOCULAR LENSES
12.3.1 MARKET OVERVIEW
12.3.2 MARKET SIZE & FORECAST
12.3.3 INTRAOCULAR LENSES: MARKET BY GEOGRAPHY
12.4 GLAUCOMA IMPLANTS
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.4.3 GLAUCOMA IMPLANTS: MARKET BY GEOGRAPHY
12.5 CORNEAL IMPLANTS
12.5.1 MARKET OVERVIEW
12.5.2 MARKET SIZE & FORECAST
12.5.3 CORNEAL IMPLANTS: MARKET BY GEOGRAPHY
12.6 OTHERS
12.6.1 MARKET OVERVIEW
12.6.2 MARKET SIZE & FORECAST
12.6.3 OTHERS: MARKET BY GEOGRAPHY
13 APPLICATION
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 CATARACT SURGERY
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 CATARACT SURGERY: MARKET BY GEOGRAPHY
13.4 GLAUCOMA SURGERY
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 GLAUCOMA SURGERY: MARKET BY GEOGRAPHY
13.5 OTHERS
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 OTHERS: MARKET BY GEOGRAPHY
14 END-USER
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 HOSPITALS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 HOSPITALS: MARKET BY GEOGRAPHY
14.4 AMBULATORY SURGERY CENTERS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 AMBULATORY SURGERY CENTERS: MARKET BY GEOGRAPHY
14.5 OPHTHALMIC CLINICS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 OPHTHALMIC CLINICS: MARKET BY GEOGRAPHY
15 GEOGRAPHY
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 GEOGRAPHIC OVERVIEW
16 NORTH AMERICA
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.3 NORTH AMERICA: PRODUCT SEGMENTATION
16.4 NORTH AMERICA: APPLICATION SEGMENTATION
16.5 NORTH AMERICA: END-USER SEGMENTATION
16.6 NORTH AMERICA: KEY COUNTRIES
16.6.1 US: MARKET SIZE & FORECAST
16.6.2 CANADA: MARKET SIZE & FORECAST
17 EUROPE
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 EUROPE: PRODUCT SEGMENTATION
17.4 EUROPE: APPLICATION SEGMENTATION
17.5 EUROPE: END-USER SEGMENTATION
17.6 EUROPE: KEY COUNTRIES
17.6.1 GERMANY: MARKET SIZE & FORECAST
17.6.2 UK: MARKET SIZE & FORECAST
17.6.3 FRANCE: MARKET SIZE & FORECAST
17.6.4 SPAIN: MARKET SIZE & FORECAST
17.6.5 ITALY: MARKET SIZE & FORECAST
18 APAC
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 APAC: PRODUCT SEGMENTATION
18.4 APAC: APPLICATION SEGMENTATION
18.5 APAC: END-USER SEGMENTATION
18.6 APAC: KEY COUNTRIES
18.6.1 CHINA: MARKET SIZE & FORECAST
18.6.2 JAPAN: MARKET SIZE & FORECAST
18.6.3 INDIA: MARKET SIZE & FORECAST
18.6.4 AUSTRALIA: MARKET SIZE & FORECAST
18.6.5 SOUTH KOREA: MARKET SIZE & FORECAST
19 LATIN AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 LATIN AMERICA: PRODUCT SEGMENTATION
19.4 LATIN AMERICA: APPLICATION SEGMENTATION
19.5 LATIN AMERICA: END-USER SEGMENTATION
19.6 LATIN AMERICA: KEY COUNTRIES
19.6.1 MEXICO: MARKET SIZE & FORECAST
19.6.2 ARGENTINA: MARKET SIZE & FORECAST
19.6.3 BRAZIL: MARKET SIZE & FORECAST
20 MIDDLE EAST & AFRICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
20.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
20.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
20.6 MIDDLE EAST & AFRICA: KEY COUNTRIES
20.6.1 TURKEY: MARKET SIZE & FORECAST
20.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST
20.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
21.1 COMPETITION OVERVIEW
21.2 MARKET SHARE ANALYSIS
21.2.1 ALCON
21.2.2 JOHNSON & JOHNSON VISION
21.2.3 BAUSCH & LOMB
21.2.4 CARL ZEISS
22 PROMINENT VENDORS
22.1 ALCON
22.1.1 BUSINESS OVERVIEW
22.1.2 PRODUCT OFFERINGS
22.1.3 KEY STRATEGIES
22.1.4 KEY STRENGTHS
22.1.5 KEY OPPORTUNITIES
22.2 JOHNSON & JOHNSON
22.2.1 BUSINESS OVERVIEW
22.2.2 PRODUCT OFFERINGS
22.2.3 KEY STRATEGIES
22.2.4 KEY STRENGTHS
22.2.5 KEY OPPORTUNITIES
22.3 BAUSCH & LOMB
22.3.1 BUSINESS OVERVIEW
22.3.2 PRODUCT OFFERINGS
22.3.3 KEY STRATEGIES
22.3.4 KEY STRENGTHS
22.3.5 KEY OPPORTUNITIES
23 OTHER PROMINENT VENDORS
23.1 SECOND SIGHT
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.2 MICRO ENGINEERING SOLUTIONS
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.3 GULDEN OPHTHALMICS
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.4 AJL OPHTHALMIC S.A
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.5 EYED PHARMA
23.5.1 BUSINESS OVERVIEW
23.5.2 PRODUCT OFFERINGS
23.6 CARE GROUP
23.6.1 BUSINESS OVERVIEW
23.6.2 PRODUCT OFFERINGS
23.7 F.AD. MÜLLER SÖHNE GMBH & CO.KG
23.7.1 BUSINESS OVERVIEW
23.7.2 PRODUCT OFFERINGS
23.8 HOYA CORPORATION
23.8.1 BUSINESS OVERVIEW
23.8.2 PRODUCT OFFERING
23.9 MORCHER GMBH
23.9.1 BUSINESS OVERVIEW
23.9.2 PRODUCT OFFERINGS
23.10 OPHTEC
23.10.1 BUSINESS OVERVIEW
23.10.2 PRODUCT OFFERINGS
23.11 BVI
23.11.1 BUSINESS OVERVIEW
23.11.2 PRODUCT OFFERINGS
23.12 RAYNER INTRAOCULAR LENSES LIMITED
23.12.1 BUSINESS OVERVIEW
23.12.2 PRODUCT OFFERINGS
23.13 GLAUKOS CORPORATION
23.13.1 BUSINESS OVERVIEW
23.13.2 PRODUCT OFFERINGS
23.14 CORNEAT VISION
23.14.1 BUSINESS OVERVIEW
23.14.2 PRODUCT OFFERINGS
23.15 HUMANOPTICS
23.15.1 BUSINESS OVERVIEW
23.15.2 PRODUCT OFFERINGS
23.16 OMNI LENS
23.16.1 BUSINESS OVERVIEW
23.16.2 PRODUCT OFFERINGS
23.17 IVANTIS
23.17.1 BUSINESS OVERVIEW
23.17.2 PRODUCT OFFERINGS
23.18 INNFOCUS
23.18.1 BUSINESS OVERVIEW
23.18.2 PRODUCT OFFERINGS
23.19 POLYACTIVA PTY LTD
23.19.1 BUSINESS OVERVIEW
23.19.2 PRODUCT OFFERINGS
23.20 LAMBDAVISION
23.20.1 BUSINESS OVERVIEW
23.20.2 PRODUCT OFFERINGS
23.21 SMR OPHTHALMIC PVT. LTD.
23.21.1 BUSINESS OVERVIEW
23.21.2 PRODUCT OFFERINGS
23.22 LABTICIAN OPHTHALMICS, INC.
23.22.1 BUSINESS OVERVIEW
23.22.2 PRODUCT OFFERINGS
23.23 DEVINE MEDITECH
23.23.1 BUSINESS OVERVIEW
23.23.2 PRODUCT OFFERINGS
23.24 INNOLENS
23.24.1 BUSINESS OVERVIEW
23.24.2 PRODUCT OFFERINGS
23.25 ISTAR MEDICAL
23.25.1 BUSINESS OVERVIEW
23.25.2 PRODUCT OFFERINGS
24 REPORT SUMMARY
24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
25.1 MARKET BY GEOGRAPHY
25.2 MARKET BY PRODUCT
25.3 MARKET BY APPLICATION
25.4 MARKET BY END-USER
25.5 NORTH AMERICA: BY PRODUCT
25.6 NORTH AMERICA: BY APPLICATION
25.7 NORTH AMERICA: BY END-USER
25.8 EUROPE: BY PRODUCT
25.9 EUROPE: BY APPLICATION
25.10 EUROPE: BY END-USER
25.11 APAC: BY PRODUCT
25.12 APAC: BY APPLICATION
25.13 APAC: BY END-USER
25.14 LATIN AMERICA: BY PRODUCT
25.15 LATIN AMERICA: BY APPLICATION
25.16 LATIN AMERICA: BY END-USER
25.17 MIDDLE EAST & AFRICA: BY PRODUCT
25.18 MIDDLE EAST & AFRICA: BY APPLICATION
25.19 MIDDLE EAST & AFRICA: BY END-USER
26 APPENDIX
26.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL OPHTHALMIC IMPLANTS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 IMPACT OF RISE OF ARTIFICIAL INTELLIGENCE FOR DETECTING DIABETIC RETINOPATHY
EXHIBIT 4 IMPACT OF USE OF SYNTHETIC CORNEA IMPLANTS
EXHIBIT 5 IMPACT OF INCREASE IN USE OF ROBOTIC SURGICAL ASSISTANTS FOR EYE SURGERIES
EXHIBIT 6 IMPACT OF GROWING ADVANCEMENTS IN OPHTHALMIC DIAGNOSTIC TECHNOLOGY
EXHIBIT 7 IMPACT OF INCREASING ADOPTION OF ADVANCED OCULAR DEVICES
EXHIBIT 8 IMPACT OF INCREASE IN THE NUMBER OF CASES OF EYE-RELATED DISORDERS
EXHIBIT 9 IMPACT OF RISE IN AWARENESS OF DIAGNOSIS & TREATMENT OF EYE DISORDERS
EXHIBIT 10 IMPACT OF RISE IN PREFERENCE FOR MINIMALLY INVASIVE OPHTHALMIC SURGERY
EXHIBIT 11 IMPACT OF STRINGENT REGULATORY APPROVALS AND PRODUCT RECALLS
EXHIBIT 12 IMPACT OF INCREASE IN RISK OF SURGERY FAILURE
EXHIBIT 13 GLOBAL OPHTHALMIC IMPLANTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 14 GLOBAL OPHTHALMIC IMPLANTS MARKET BY PRODUCT
EXHIBIT 15 GLOBAL OPHTHALMIC IMPLANTS MARKET BY APPLICATION
EXHIBIT 16 GLOBAL OPHTHALMIC IMPLANTS MARKET BY END-USER
EXHIBIT 17 GLOBAL OPHTHALMIC IMPLANTS MARKET BY GEOGRAPHY
EXHIBIT 18 FIVE FORCES ANALYSIS 2021
EXHIBIT 19 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 20 GLOBAL OPHTHALMIC IMPLANTS MARKET BY PRODUCT
EXHIBIT 21 GLOBAL OPHTHALMIC IMPLANTS MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 22 GLOBAL OPHTHALMIC IMPLANTS MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 23 GLOBAL OPHTHALMIC IMPLANTS INTRAOCULAR LENSES MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 24 GLOBAL OPHTHALMIC IMPLANTS INTRAOCULAR LENSES MARKET 2021–2027 ($ MILLION)
EXHIBIT 25 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 26 GLOBAL OPHTHALMIC GLAUCOMA IMPLANTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 27 GLOBAL OPHTHALMIC GLAUCOMA IMPLANTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 28 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 29 GLOBAL OPHTHALMIC CORNEAL IMPLANTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 30 GLOBAL OPHTHALMIC CORNEAL IMPLANTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 31 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 32 GLOBAL OPHTHALMIC IMPLANTS OTHER PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 33 GLOBAL OPHTHALMIC IMPLANTS OTHER PRODUCTS MARKET 2021–2027 ($ MILLION)
EXHIBIT 34 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 35 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 36 GLOBAL OPHTHALMIC IMPLANTS MARKET BY APPLICATION
EXHIBIT 37 GLOBAL OPHTHALMIC IMPLANTS MARKET BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 38 GLOBAL OPHTHALMIC IMPLANTS MARKET BY APPLICATION: ABSOLUTE GROWTH
EXHIBIT 39 REASONS FOR THE RISING CATARACT SURGERY INCIDENCE RATES
EXHIBIT 40 GLOBAL OPHTHALMIC IMPLANTS CATARACT SURGERY MARKET 2021–2027 ($ MILLION)
EXHIBIT 41 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 42 GLOBAL OPHTHALMIC IMPLANTS GLAUCOMA SURGERY MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL OPHTHALMIC IMPLANTS GLAUCOMA SURGERY MARKET 2021–2027 ($ MILLION)
EXHIBIT 44 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 45 GLOBAL OPHTHALMIC IMPLANTS OTHER APPLICATIONS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL OPHTHALMIC IMPLANTS OTHER APPLICATIONS MARKET 2021–2027 ($ MILLION)
EXHIBIT 47 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 48 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 49 GLOBAL OPHTHALMIC IMPLANTS MARKET BY END-USER
EXHIBIT 50 GLOBAL OPHTHALMIC IMPLANTS MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 51 GLOBAL OPHTHALMIC IMPLANTS MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL OPHTHALMIC IMPLANTS HOSPITALS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 53 GLOBAL OPHTHALMIC IMPLANTS HOSPITALS MARKET 2021–2027 ($ MILLION)
EXHIBIT 54 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 55 GLOBAL OPHTHALMIC IMPLANTS AMBULATORY SURGERY CENTERS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL OPHTHALMIC IMPLANTS AMBULATORY SURGERY CENTERS MARKET 2021–2027 ($ MILLION)
EXHIBIT 57 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 58 GLOBAL OPHTHALMIC IMPLANTS OPHTHALMIC CLINICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 59 GLOBAL OPHTHALMIC IMPLANTS OPHTHALMIC CLINICS MARKET 2021–2027 ($ MILLION)
EXHIBIT 60 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 61 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 62 GLOBAL OPHTHALMIC IMPLANTS MARKET BY GEOGRAPHY
EXHIBIT 63 GLOBAL OPHTHALMIC IMPLANTS MARKET BY REGION: INCREMENTAL GROWTH
EXHIBIT 64 GLOBAL OPHTHALMIC IMPLANTS MARKET BY REGION: ABSOLUTE GROWTH
EXHIBIT 65 NORTH AMERICA OPHTHALMIC IMPLANTS MARKET: KEY COUNTRIES ($ MILLION)
EXHIBIT 66 NORTH AMERICA OPHTHALMIC IMPLANTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 67 OPHTHALMIC IMPLANTS MARKET IN NORTH AMERICA 2021–2027 ($ MILLION)
EXHIBIT 68 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 69 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 70 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 71 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 72 OPHTHALMIC IMPLANTS MARKET IN THE US 2021–2027 ($ MILLION)
EXHIBIT 73 OPHTHALMIC IMPLANTS MARKET IN CANADA 2021–2027 ($ MILLION)
EXHIBIT 74 EUROPE OPHTHALMIC IMPLANTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 75 EUROPE OPHTHALMIC IMPLANTS MARKET: KEY COUNTRIES ($ MILLION)
EXHIBIT 76 OPHTHALMIC IMPLANTS MARKET IN EUROPE 2021–2027 ($ MILLION)
EXHIBIT 77 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 78 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 79 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 80 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 81 OPHTHALMIC IMPLANTS MARKET IN GERMANY 2021–2027 ($ MILLION)
EXHIBIT 82 OPHTHALMIC IMPLANTS MARKET IN THE UK 2021–2027 ($ MILLION)
EXHIBIT 83 OPHTHALMIC IMPLANTS MARKET IN FRANCE 2021–2027 ($ MILLION)
EXHIBIT 84 OPHTHALMIC IMPLANTS MARKET IN SPAIN 2021–2027 ($ MILLION)
EXHIBIT 85 OPHTHALMIC IMPLANTS MARKET IN ITALY 2021–2027 ($ MILLION)
EXHIBIT 86 APAC OPHTHALMIC IMPLANTS MARKET: KEY COUNTRIES ($ MILLION)
EXHIBIT 87 APAC OPHTHALMIC IMPLANTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 88 OPHTHALMIC IMPLANTS MARKET IN APAC 2021–2027 ($ MILLION)
EXHIBIT 89 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 90 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 91 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 92 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 93 OPHTHALMIC IMPLANTS MARKET IN CHINA 2021–2027 ($ MILLION)
EXHIBIT 94 OPHTHALMIC IMPLANTS MARKET IN JAPAN 2021–2027 ($ MILLION)
EXHIBIT 95 OPHTHALMIC IMPLANTS MARKET IN INDIA 2021–2027 ($ MILLION)
EXHIBIT 96 OPHTHALMIC IMPLANTS MARKET IN AUSTRALIA 2021–2027 ($ MILLION)
EXHIBIT 97 OPHTHALMIC IMPLANTS MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)
EXHIBIT 98 LATIN AMERICA OPHTHALMIC IMPLANTS MARKET: KEY COUNTRIES ($ MILLION)
EXHIBIT 99 LATIN AMERICA OPHTHALMIC IMPLANTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 100 OPHTHALMIC IMPLANTS MARKET IN LATIN AMERICA 2021–2027 ($ MILLION)
EXHIBIT 101 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 102 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 103 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 104 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 105 OPHTHALMIC IMPLANTS MARKET IN MEXICO 2021–2027 ($ MILLION)
EXHIBIT 106 OPHTHALMIC IMPLANTS MARKET IN ARGENTINA 2021–2027 ($ MILLION)
EXHIBIT 107 OPHTHALMIC IMPLANTS MARKET IN BRAZIL 2021–2027 ($ MILLION)
EXHIBIT 108 MIDDLE EAST & AFRICA OPHTHALMIC IMPLANTS MARKET: KEY COUNTRIES ($ MILLION)
EXHIBIT 109 MIDDLE EAST & AFRICA OPHTHALMIC IMPLANTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 110 OPHTHALMIC IMPLANTS MARKET IN THE MIDDLE EAST & AFRICA 2021–2027 ($ MILLION)
EXHIBIT 111 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 112 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 113 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 114 INCREMENTAL GROWTH IN THE MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 115 OPHTHALMIC IMPLANTS MARKET IN TURKEY 2021–2027 ($ MILLION)
EXHIBIT 116 OPHTHALMIC IMPLANTS MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)
EXHIBIT 117 OPHTHALMIC IMPLANTS MARKET IN SOUTH AFRICA 2021–2027 ($ MILLION)
EXHIBIT 118 OPHTHALMIC IMPLANTS MARKET SHARE ANALYSIS 2021
EXHIBIT 119 REVENUES 2018-2020 ($ MILLION)
EXHIBIT 120 JOHNSON & JOHNSON ANNUAL REVENUES 2018-2020 ($ BILLION)
EXHIBIT 121 BAUSCH & LOMB ANNUAL REVENUE 2018-2020 ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 SELECTED NEW AND EMERGING MICROINVASIVE GLAUCOMA SURGERY IMPLANTS AND OTHER TECHNOLOGIES
TABLE 4 PRODUCT RECALLS
TABLE 5 GLAUCOMA IMPLANTS LAUNCHED BY VARIOUS KEY PLAYERS
TABLE 6 CLASSIFICATION OF ORBITAL IMPLANTS
TABLE 7 BLINDNESS BY PROVINCE
TABLE 8 CAUSES OF BLINDNESS
TABLE 9 EYE CONDITIONS IN AUSTRALIA
TABLE 10 COMPARISON OF CATARACT SURGERY COST ($)– US VS MEXICO
TABLE 11 ALCON: MAJOR PRODUCT OFFERINGS
TABLE 12 JOHNSON & JOHNSON VISION: MAJOR PRODUCT OFFERINGS
TABLE 13 BAUSCH & LOMB: MAJOR PRODUCT OFFERINGS
TABLE 14 SECOND SIGHT: MAJOR PRODUCT OFFERINGS
TABLE 15 MICRO ENGINEERING SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 16 GULDEN OPHTHALMICS: MAJOR PRODUCT OFFERINGS
TABLE 17 AJL OPHTHALMIC: MAJOR PRODUCT OFFERINGS
TABLE 18 EYED PHARMA: MAJOR PRODUCT OFFERINGS
TABLE 19 CARE GROUP: MAJOR PRODUCT OFFERINGS
TABLE 20 F.AD. MÜLLER SÖHNE: MAJOR PRODUCT OFFERINGS
TABLE 21 HOYA: MAJOR PRODUCT OFFERINGS
TABLE 22 MORCHER: MAJOR PRODUCT OFFERINGS
TABLE 23 OPHTEC.: MAJOR PRODUCT OFFERINGS
TABLE 24 BVI: MAJOR PRODUCT OFFERINGS
TABLE 25 RAYNER INTRAOCULAR LENSES LIMITED: MAJOR PRODUCT OFFERINGS
TABLE 26 GLAUKOS: MAJOR PRODUCT OFFERINGS
TABLE 27 CORNEAT VISION: MAJOR PRODUCT OFFERINGS
TABLE 28 HUMANOPTICS: MAJOR PRODUCT OFFERINGS
TABLE 29 OMNI LENS: MAJOR PRODUCT OFFERINGS
TABLE 30 IVANTIS: MAJOR PRODUCT OFFERINGS
TABLE 31 INNFOCUS: MAJOR PRODUCT OFFERINGS
TABLE 32 POLYACTIVA PTY LTD: MAJOR PRODUCT OFFERINGS
TABLE 33 LAMBDAVISION: MAJOR PRODUCT OFFERINGS
TABLE 34 SMR OPHTHALMIC: MAJOR PRODUCT OFFERINGS
TABLE 35 LABTICIAN OPHTHALMICS: MAJOR PRODUCT OFFERINGS
TABLE 36 DEVINE MEDITECH: MAJOR PRODUCT OFFERINGS
TABLE 37 INNOLENS: MAJOR PRODUCT OFFERINGS
TABLE 38 ISTAR MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 39 GLOBAL OPHTHALMIC IMPLANTS MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)
TABLE 40 GLOBAL OPHTHALMIC IMPLANTS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 41 GLOBAL OPHTHALMIC IMPLANTS MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 42 GLOBAL OPHTHALMIC IMPLANTS MARKET BY PRODUCT 2021−2027 (%)
TABLE 43 GLOBAL OPHTHALMIC IMPLANTS MARKET BY APPLICATION 2021−2027 ($ MILLION)
TABLE 44 GLOBAL OPHTHALMIC IMPLANTS MARKET BY APPLICATION 2021−2027 (%)
TABLE 45 GLOBAL OPHTHALMIC IMPLANTS MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 46 GLOBAL OPHTHALMIC IMPLANTS MARKET BY END-USER 2021−2027 (%)
TABLE 47 NORTH AMERICA OPHTHALMIC IMPLANTS MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 48 NORTH AMERICA OPHTHALMIC IMPLANTS MARKET BY PRODUCT 2021−2027 (%)
TABLE 49 NORTH AMERICA OPHTHALMIC IMPLANTS MARKET BY APPLICATION 2021−2027 ($ MILLION)
TABLE 50 NORTH AMERICA OPHTHALMIC IMPLANTS MARKET BY APPLICATION 2021−2027 (%)
TABLE 51 NORTH AMERICA OPHTHALMIC IMPLANTS MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 52 NORTH AMERICA OPHTHALMIC IMPLANTS MARKET BY END-USER 2021−2027 (%)
TABLE 53 EUROPE OPHTHALMIC IMPLANTS MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 54 EUROPE OPHTHALMIC IMPLANTS MARKET BY PRODUCT 2021−2027 (%)
TABLE 55 EUROPE OPHTHALMIC IMPLANTS MARKET BY APPLICATION 2021−2027 ($ MILLION)
TABLE 56 EUROPE OPHTHALMIC IMPLANTS MARKET BY APPLICATION 2021−2027 (%)
TABLE 57 EUROPE OPHTHALMIC IMPLANTS MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 58 EUROPE OPHTHALMIC IMPLANTS MARKET BY END-USER 2021−2027 (%)
TABLE 59 APAC OPHTHALMIC IMPLANTS MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 60 APAC OPHTHALMIC IMPLANTS MARKET BY PRODUCT 2021−2027 (%)
TABLE 61 APAC OPHTHALMIC IMPLANTS MARKET BY APPLICATION 2021−2027 ($ MILLION)
TABLE 62 APAC OPHTHALMIC IMPLANTS MARKET BY APPLICATION 2021−2027 (%)
TABLE 63 APAC OPHTHALMIC IMPLANTS MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 64 APAC OPHTHALMIC IMPLANTS MARKET BY END-USER 2021−2027 (%)
TABLE 65 LATIN AMERICA OPHTHALMIC IMPLANTS MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 66 LATIN AMERICA OPHTHALMIC IMPLANTS MARKET BY PRODUCT 2021−2027 (%)
TABLE 67 LATIN AMERICA OPHTHALMIC IMPLANTS MARKET BY APPLICATION 2021−2027 ($ MILLION)
TABLE 68 LATIN AMERICA OPHTHALMIC IMPLANTS MARKET BY APPLICATION 2021−2027 (%)
TABLE 69 LATIN AMERICA OPHTHALMIC IMPLANTS MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 70 LATIN AMERICA OPHTHALMIC IMPLANTS MARKET BY END-USER 2021−2027 (%)
TABLE 71 MIDDLE EAST & AFRICA OPHTHALMIC IMPLANTS MARKET BY PRODUCT 2021−2027 ($ MILLION)
TABLE 72 MIDDLE EAST & AFRICA OPHTHALMIC IMPLANTS MARKET BY PRODUCT 2021−2027 (%)
TABLE 73 MIDDLE EAST & AFRICA OPHTHALMIC IMPLANTS MARKET BY APPLICATION 2021−2027 ($ MILLION)
TABLE 74 MIDDLE EAST & AFRICA OPHTHALMIC IMPLANTS MARKET BY APPLICATION 2021−2027 (%)
TABLE 75 MIDDLE EAST & AFRICA OPHTHALMIC IMPLANTS MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 76 MIDDLE EAST & AFRICA OPHTHALMIC IMPLANTS MARKET BY END-USER 2021−2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
